The ADA’s Standards of Care shape diabetes treatment, technology access, and insurance coverage worldwide. In this episode, we break down the latest updates, including a major new recommendation that all people with type 2 diabetes—regardless of insulin use—have access to CGM. We also explore the ADA’s stance on emerging diabetes technologies and why these guidelines are considered the “gold standard” for diabetes management. Joining me is Dr. Grazia Aleppo, a leading endocrinologist and former Chair of the ADA’s Diabetes Technology Section, who shares insights into how these recommendations are developed and their impact on diabetes care.

DISCLAIMERS: This podcast is not medical advice. Always consult with your doctor before making changes to your health care.

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

How the ADA Sets its Standards of Care for Diabetes